Michael Kauffman, Director at Karyopharm Therapeutics Inc. (KPTI), sold 26,942 shares at $9.86 ($266K) on 2022-02-07, disclosed to the SEC on 2022-02-09.
Open-market sale of $266k KPTI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.86 | 6,707 | $66K | 24.9% |
| 2 | $9.86 | 6,707 | $66K | 24.9% |
| 3 | $9.86 | 6,764 | $67K | 25.1% |
| 4 | $9.86 | 6,764 | $67K | 25.1% |
| Total | $9.86 avg | 26,942 | $266K | 100% |
| Filing → |
| KPTI | SELL | 2022-03-02 | $128K | — | Filing → |
| KPTI | SELL | 2022-02-22 | $440K | — | Filing → |
| KZR | SELL | 2022-01-05 | $82K | — | Filing → |